Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,184 | -116,537 | -87,966 | -34,506 | -22,811 |
| Depreciation Amortization | 359 | 374 | 49,021 | 195 | 183 |
| Income taxes - deferred | 431 | N/A | N/A | -2,354 | -404 |
| Accounts payable and accrued liabilities | 7,751 | -2,600 | N/A | N/A | N/A |
| Other Working Capital | 8,710 | -4,917 | 2,368 | -152 | -180 |
| Other Operating Activity | -28,338 | 84,153 | 8,153 | 7,904 | 8,000 |
| Operating Cash Flow | $-47,271 | $-39,527 | $-28,424 | $-28,913 | $-15,212 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -70,314 | -45,287 | N/A | N/A | N/A |
| Net Acquisitions | N/A | N/A | N/A | N/A | 11,035 |
| Investing Cash Flow | $-70,314 | $-45,287 | $N/A | $N/A | $11,035 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 133,522 | 33,017 | N/A | 1 | 14,380 |
| Other Financing Activity | 0 | 0 | 0 | -450 | 95,201 |
| Financing Cash Flow | $133,522 | $33,017 | $N/A | $-449 | $109,581 |
| Beginning Cash Position | 4,612 | 56,409 | 84,833 | 114,195 | 8,791 |
| End Cash Position | 20,549 | 4,612 | 56,409 | 84,833 | 114,195 |
| Net Cash Flow | $15,937 | $-51,797 | $-28,424 | $-29,362 | $105,404 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,271 | -39,527 | -28,424 | -28,913 | -15,212 |
| Free Cash Flow | -47,271 | -39,527 | -28,424 | -28,913 | -15,212 |